Ancora Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $396K | Sell |
3,825
-1,852
| -33% | -$165K | 0.01% | 584 |
|
|
2026
Q1 | $408K | Sell |
5,677
-39
| -0.7% | -$3K | 0.01% | 567 |
|
|
2025
Q4 | $454K | Buy |
5,716
+486
| +9% | +$38.3K | 0.01% | 570 |
|
|
2025
Q3 | $394K | Sell |
5,230
-874
| -14% | -$59.9K | 0.01% | 594 |
|
|
2025
Q2 | $421K | Sell |
6,104
-1,809
| -23% | -$119K | 0.01% | 565 |
|
|
2025
Q1 | $536K | Sell |
7,913
-1,215
| -13% | -$72.7K | 0.01% | 507 |
|
|
2024
Q4 | $410K | Sell |
9,128
-29,365
| -76% | -$1.65M | 0.01% | 558 |
|
|
2024
Q3 | $2.42M | Sell |
38,493
-27,801
| -42% | -$1.62M | 0.06% | 249 |
|
|
2024
Q2 | $3.92M | Sell |
66,294
-379,716
| -85% | -$23.8M | 0.1% | 187 |
|
|
2024
Q1 | $35.6M | Sell |
446,010
-4,112
| -0.9% | -$314K | 0.81% | 31 |
|
|
2023
Q4 | $35.5M | Sell |
450,122
-7,145
| -2% | -$509K | 0.83% | 30 |
|
|
2023
Q3 | $31.9M | Buy |
457,267
+68,005
| +17% | +$4.82M | 0.85% | 28 |
|
|
2023
Q2 | $26.9M | Buy |
389,262
+3,035
| +0.8% | +$216K | 0.71% | 31 |
|
|
2023
Q1 | $28.7M | Buy |
386,227
+10,456
| +3% | +$877K | 0.81% | 28 |
|
|
2022
Q4 | $35M | Buy |
375,771
+6,741
| +2% | +$650K | 1.01% | 21 |
|
|
2022
Q3 | $35.2M | Buy |
369,030
+3,982
| +1% | +$394K | 1.09% | 16 |
|
|
2022
Q2 | $33.8M | Sell |
365,048
-1,029
| -0.3% | -$100K | 0.95% | 19 |
|
|
2022
Q1 | $37.1M | Sell |
366,077
-31,805
| -8% | -$3.34M | 0.9% | 21 |
|
|
2021
Q4 | $41M | Sell |
397,882
-253
| -0.1% | -$23.4K | 0.97% | 19 |
|
|
2021
Q3 | $33.8M | Buy |
398,135
+33,610
| +9% | +$2.82M | 0.87% | 19 |
|
|
2021
Q2 | $30.4M | Sell |
364,525
-1,462
| -0.4% | -$120K | 0.79% | 22 |
|
|
2021
Q1 | $27.5M | Buy |
365,987
+8,058
| +2% | +$587K | 0.76% | 24 |
|
|
2020
Q4 | $24.4M | Buy |
357,929
+10,408
| +3% | +$677K | 0.79% | 26 |
|
|
2020
Q3 | $20.3M | Buy |
347,521
+34,920
| +11% | +$2.17M | 0.81% | 30 |
|
|
2020
Q2 | $20.3M | Buy |
312,601
+18,928
| +6% | +$1.19M | 0.85% | 24 |
|
|
2020
Q1 | $17.4M | Buy |
293,673
+53,628
| +22% | +$3.58M | 0.81% | 23 |
|
|
2019
Q4 | $17.8M | Buy |
240,045
+184,736
| +334% | +$13M | 0.66% | 38 |
|
|
2019
Q3 | $3.49M | Sell |
55,309
-1,204
| -2% | -$71.3K | 0.15% | 168 |
|
|
2019
Q2 | $3.08M | Sell |
56,513
-1,339
| -2% | -$72.1K | 0.14% | 173 |
|
|
2019
Q1 | $3.12M | Sell |
57,852
-2,018
| -3% | -$125K | 0.14% | 181 |
|
|
2018
Q4 | $3.92M | Sell |
59,870
-1,111
| -2% | -$82.9K | 0.19% | 160 |
|
|
2018
Q3 | $4.8M | Buy |
60,981
+5,470
| +10% | +$391K | 0.18% | 161 |
|
|
2018
Q2 | $3.57M | Sell |
55,511
-1,038
| -2% | -$68.4K | 0.16% | 184 |
|
|
2018
Q1 | $3.52M | Sell |
56,549
-1,053
| -2% | -$75.6K | 0.16% | 181 |
|
|
2017
Q4 | $4.17M | Buy |
57,602
+4,463
| +8% | +$324K | 0.22% | 144 |
|
|
2017
Q3 | $4.32M | Sell |
53,139
-16,733
| -24% | -$1.32M | 0.25% | 128 |
|
|
2017
Q2 | $5.62M | Buy |
69,872
+3,858
| +6% | +$305K | 0.36% | 76 |
|
|
2017
Q1 | $5.18M | Buy |
66,014
+3,241
| +5% | +$259K | 0.35% | 84 |
|
|
2016
Q4 | $4.95M | Buy |
62,773
+48,238
| +332% | +$3.9M | 0.36% | 67 |
|
|
2016
Q3 | $1.29M | Buy |
14,535
+10,493
| +260% | +$990K | 0.13% | 189 |
|
|
2016
Q2 | $387K | Buy |
4,042
+737
| +22% | +$73.5K | 0.05% | 355 |
|
|
2016
Q1 | $343K | Buy |
+3,305
| New | +$321K | 0.04% | 364 |
|
Other funds holding CVS
Ancora Advisors's CVS Position: Q2 2026 in Review
Ancora Advisors reduced its CVS Health (CVS) stake by 33% in Q2 2026, selling an estimated $165K and leaving 3,825 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #584.
Ancora Advisors first reported a position in CVS in Q1 2016 and has held it in 42 quarters since. The position peaked at $41M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Ancora Advisors held 3,825 shares of CVS Health worth $396K as of Q2 2026.
- Ancora Advisors sold 1,852 CVS Health shares in Q2 2026, an estimated $165K.
- CVS Health made up 0.01% of Ancora Advisors's portfolio in Q2 2026, its #584 holding.
- Ancora Advisors first reported a position in CVS Health in Q1 2016 and has held it in 42 quarters since.
- Ancora Advisors's CVS Health position peaked at $41M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.